• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Imlunestrant Alone or With Verzenios Improved PROs in Advanced Breast Cancer

by MM360 Staff | Jun 2, 2025 | Uncategorized

Source: CureToday articles Imlunestrant alone or in combination with Verzenios improved patient-reported outcomes in ER+, HER2– advanced breast cancer following endocrine therapy. Read More

Fotivda Monotherapy Demonstrated Efficacy in Previously Treated Metastatic RCC

by MM360 Staff | Jun 2, 2025 | Uncategorized

Source: CureToday articles Dr. Alexander Chehrazi-Raffle discusses findings from the phase 3 TiNivo-2 trial, designed to evaluate treatment with Fotivda in patients with metastatic renal cell carcinoma. Read More

Cancer Survivors Look Forward, Not Backward

by MM360 Staff | Jun 2, 2025 | Uncategorized

Source: CureToday articles As a cancer survivor I explain the importance of looking forward to life. Read More

Initial Enhertu Combo Improves Survival in HER2+ Advanced Breast Cancer

by MM360 Staff | Jun 2, 2025 | Uncategorized

Source: CureToday articles Adding Enhertu to Perjeta improved time without cancer growth versus standard care in advanced HER2-positive breast cancer, as per data from DESTINY-Breast09. Read More

Exercise Improves Survival End Points After High-Risk CRC Treatment

by MM360 Staff | Jun 2, 2025 | Uncategorized

Source: CureToday articles Participation in a structured exercise program following surgery and adjuvant chemo improved key survival end points in stage 3 and high-risk stage 2 CRC. Read More

Imfinzi Combo Boosts Survival in Resectable Gastric and GEJ Cancer

by MM360 Staff | Jun 2, 2025 | Uncategorized

Source: CureToday articles Adding Imfinzi to fluorouracil-based chemo improved event-free survival and response rates in resectable gastric and gastroesophageal junction cancer. Read More
« Older Entries
Next Entries »

Recent Content

  • LAMP5 modulates IRF4 stability and nuclear transport: a critical mechanism in myeloma progression and therapy
  • High glutamate levels in the bone marrow of multiple myeloma patients promote osteoclast formation: a novel target for osteolytic bone disease
  • Value of Spectral CT Techniques for the Assessment of Bone Marrow Infiltration in Multiple Myeloma: A Systematic Literature Review
  • EHA 2025: Early Data Support Tocilizumab Use to Enable Outpatient Talquetamab Dosing in R/R Multiple Myeloma
  • VIDEO: Four drugs ‘appear to be better’ in treatment of newly diagnosed multiple myeloma
  • VIDEO: Cilta-cel may offer ‘cure’ in relapsed, refractory multiple myeloma
  • Treatment-related cognitive changes in multiple myeloma: A systematic review and meta-analysis
  • NCCN Flash Update: Linvoseltamab Added as Preferred Regimen After 4 Prior Therapies for Multiple Myeloma
  • FDA Panel Rejects Belantamab Mafodotin Combinations for Multiple Myeloma, Citing Safety Concerns
  • FDA Votes Against Proposed Blenrep Treatment Combo’s for Multiple Myeloma
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT